Omkar Pharmachem Ltd.BSE: OMKARPH

Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Board Meeting Held On 12Th September 2024 For Approval Of Unaudited Financial Results For Quarter And Half Year Ended On 30.09.2024

· Issued by Omkar Pharmachem Ltd. via BSE India

Filed with BSE ·

Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held on 12th November, 2024 has considered and approved the following business: Unaudited Financial Results of the Company along with Statement of Assets and Liabilities, Cash Flow Statement and Limited Review Report for the Quarter and half year ended on 30th September, 2024.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Omkar Pharmachem Ltd. on 6ix

Later from Omkar Pharmachem

All Omkar Pharmachem news releases